Dash, Satya

Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol

Xiao, C., Dash, S., Morgantini, C., Hegele, R. A., & Lewis, G. F. (2016) · Diabetes

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 212

New insights into the regulation of chylomicron production

Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 194

Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans

Xiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology

Diabetes Treatment and ManagementLipid metabolism and disorders

Cited by 164

Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations

Dash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · Diabetes

Pancreatic function and diabetesDiabetes Management and Research

Cited by 108

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men

Dash, S., Xiao, C., Morgantini, C., Szeto, L., & Lewis, G. F. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology

Sirtuins and Resveratrol in MedicineCholesterol and Lipid Metabolism

Cited by 102

Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update

Pedersen, S. D., Manjoo, P., Dash, S., Jain, A., Pearce, N., & Poddar, M. (2025) · Canadian Medical Association Journal

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 78

Opportunities to optimize lifestyle interventions in combination with glucagon‐like peptide ‐1‐based therapy

Dash, S. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 24

Effects of intranasal insulin on endogenous glucose production in insulin‐resistant men

Xiao, C., Dash, S., Stahel, P., & Lewis, G. F. (2018) · Diabetes, Obesity and Metabolism

Pancreatic function and diabetesDiabetes Management and Research

Cited by 19